Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 40 for your search:
Drug:
FOLFOX regimen
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II/III Randomized Study of Fluorouracil/Leucovorin with vs without Oxaliplatin for Inoperable Metastatic Colorectal Cancer (Summary Last Modified 03/98)
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
FRE-DEB95-OXA-01
, EU-96023
2.
Phase III Randomized Study of Leucovorin Calcium Plus Fluorouracil With Either Irinotecan or Oxaliplatin in Patients With Recurrent Metastatic Colorectal Cancer (Summary Last Modified 05/2000)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
FRE-GERCOR-C97-3/CPTF308
, FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260
3.
Phase III Randomized Study of Chronomodulated Versus Nonchronomodulated Administration of Fluorouracil, Leucovorin Calcium, and Oxaliplatin as First Line Treatment in Patients With Locoregionally Recurrent or Metastatic Colorectal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18-75
Sponsor:
Protocol IDs:
EORTC-05963
, NCT00003287
4.
Phase III Randomized Study of Combinations of Oxaliplatin, Fluorouracil, Leucovorin Calcium, and Irinotecan as Initial Therapy in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-N9741
, CAN-NCIC-CO13, CLB-89804, E-N9741, SWOG-N9741, N9741, NCT00003594, CO13
5.
Phase III Study of Fluorouracil and Leucovorin Calcium With or Without Oxaliplatin in Patients With Stage II or III Carcinoma of the Colon
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
Any age
Sponsor:
NCI
Protocol IDs:
NSABP-C-07
, NCT00004931
6.
Phase III Randomized Study of Irinotecan Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Colorectal Cancer Previously Treated With Fluorouracil
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-N9841
, ECOG-N9841, SWOG-N9841, NCT00005036, N9841
7.
Phase III Randomized Study of Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Patients With Metastatic Colorectal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
FRE-GERCOR-OPTIMOX-2000
, EU-20034, NCT00006468
8.
Phase III Study of Surgery With or Without Neoadjuvant and Adjuvant Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Resectable Colorectal Liver Metastases
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
EORTC-40983
, AGITG-EORTC-40983, ALM-CAO-EORTC-40983, CRUK-LON-EORTC-40983, FFCD-EORTC-40983, EU-20048, CRC-EORTC-40983, NCT00006479
9.
Phase III Randomized Study of Fluorouracil With Leucovorin Calcium and Either Irinotecan or Oxaliplatin in Patients With Unresectable Metastatic Colorectal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MRC-CR08-FOCUS
, EU-20038, ISRCTN79877428, NCT00008060
10.
Phase III Randomized Study of Fluorouracil and Leucovorin Calcium Versus Oxaliplatin Alone Versus Fluorouracil, Leucovorin Calcium, and Oxaliplatin in Patients With Metastatic Colorectal Carcinoma (Summary Last Modified 04/2002)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
SANOFI-EFC4584
, BRCC-00036, NCT00008281
11.
Phase III Randomized Study of Oxaliplatin, Fluorouracil, and Leucovorin Calcium With or Without Bevacizumab Versus Bevacizumab Only in Patients With Previously Treated Advanced or Metastatic Colorectal Adenocarcinoma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
E-3200
, NCT00025337, E3200
12.
Phase III Randomized Study of Operative Debulking and Systemic Chemotherapy With or Without Intra- and Peri-Operative Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Low-Grade Gastrointestinal Adenocarcinoma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-03-C-0085
, NCT00056108
13.
Phase III Randomized Study of Oxaliplatin, Fluorouracil, and Leucovorin Calcium With or Without PTK787/ZK 222584 in Patients With Refractory or Recurrent Metastatic Adenocarcinoma of the Colon or Rectum
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UCLA-0304011
, NOVARTIS-CPTK787-0133/304946, NCT00068679
14.
Phase III Randomized Study of Adjuvant Irinotecan, Fluorouracil, and Leucovorin Calcium Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium Versus Fluorouracil and Leucovorin Calcium in Patients With Stage II or III Rectal Cancer Receiving Combined Radiotherapy and Fluorouracil Either Preoperatively or Postoperatively
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ECOG-E3201
, E3201, NCT00068692
15.
Phase III Randomized Study of Fluorouracil, Leucovorin Calcium, Oxaliplatin, and Bevacizumab Versus Capecitabine, Oxaliplatin, and Bevacizumab in Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0303
, S0303, ECOG-S0303, NCT00070122
16.
Phase III Randomized Study of Fluorouracil and Leucovorin Calcium With Irinotecan or Oxaliplatin and With or Without Cetuximab in Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CALGB-80203
, NCT00077233
17.
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
NO16966
, NCT00069095
18.
Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CA225014
, NCT00061815
19.
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CPTK787 0135/306241
, CONFIRM 1, NCT00056459
20.
Phase III Randomized Study of Adjuvant Chemotherapy Comprising Fluorouracil, Leucovorin Calcium, and Oxaliplatin With Versus Without Bevacizumab in Patients With Resected Stage II or III Adenocarcinoma of the Colon
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NSABP-C-08
, NCT00096278
21.
Phase III Randomized Study of Adjuvant Oxaliplatin, Leucovorin Calcium, and Fluorouracil (FOLFOX-4) Versus Bevacizumab and FOLFOX-4 Versus Bevacizumab, Oxaliplatin, and Capecitabine in Patients With High-Risk Stage II or Stage III Colon Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UCLA-0412086-01
, ROCHE-BO17920A, NCT00112918
22.
Phase II Study of Fluorouracil, Leucovorin, and Oxaliplatin for Colorectal Cancer Resistant to Fluorouracil and Leucovorin Alone (Summary Last Modified 03/98)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 75
Sponsor:
Protocol IDs:
FRE-FOLFOX-3-4
, EU-96022
23.
Phase II Study of Oxaliplatin and Fluorouracil Plus Leucovorin Calcium in Patients with Unresectable Metastatic Adenocarcinoma of the Colon or Rectum
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-974651
, NCCTG-97-46-51, NCT00003834
24.
Phase II Pilot Study of Oxaliplatin Combined with Fluorouracil and Leucovorin Calcium in Patients with Advanced Adenocarcinoma of the Colon or Rectum
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
NYU-9863
, SANOFI-EFC7132, NCI-G99-1593, NCT00004102
25.
Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin Calcium in Patients With Recurrent or Metastatic Carcinoma of the Esophagus or Gastric Cardia
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UCCRC-10015
, NCI-T99-0010, NCT00004127, T99-0010
Select All on Page
1
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute